"/> Novus Biologicals™ Antigène protéique recombinant… | B-LABO France

Novus Biologicals™ Antigène protéique recombinant Ellis van Creveld syndrome

Réf. : BL-RE-052261Réf. fabricant : 18298469 0.1mL
242,97 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
2121
Espèces
Human
Méthode de purification
Chromatography
Pureté
>80%
Concentration
0.5mg/mL
Marque
Novus Biologicals

A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human EVC. The Ellis van Creveld syndrome Recombinant Protein Antigen is derived from E. coli. The Ellis van Creveld syndrome Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.

This is a blocking peptide for NBP1-84038. This is a human recombinant protein expressed in E. coli with a N-terminal His-ABP tag and purified with IMAC chromatography.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-052261
Réf. fabricant18298469
Gene ID (Entrez)2121
EspècesHuman
Méthode de purificationChromatography
Pureté>80%
Concentration0.5mg/mL
Contenu et stockageStore at -20°C. Avoid freeze-thaw cycles.
FormulePBS and 1M Urea, pH 7.4.
À utiliser avec (application)Blocking/Neutralizing, Control
Symbole de gène(s)EVC
Type d’étiquetteUnlabeled
Poids moléculaire29kDa
Type de produitEllis van Creveld syndrome
Quantité0.1mL
État réglementaireRUO
SourceE.Coli
Réactivité spécifiqueThis recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP1-84038. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml
ImmunogèneETGSPSRRRKREVQMSKDKEAVDECEPPSNSNITAFALKAKVIYPINQKFRPLADGSSNPSLHENLKQAVLPHQPVEASPSSSLGSLSQGEKDDCSSSSSVHS
Une question, une configuration particulière ?
Contactez-nous pour un devis.